BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Bot Chart, page-6013

  1. 29 Posts.
    lightbulb Created with Sketch. 2
    A lot of confirmation bias going on, in my opinion I don't think a mid-cycle review says anything significantly different to what we know now. Plenty of time for any issues to be raised between now and potential final approval later in the year. I hope I am wrong though.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.